Literature DB >> 26780925

Bacterial profile and bone healing in rats receiving cancer therapeutic doses of bisphosphonates and corticosteroids: a pilot study.

Z Jabbour1, C do Nascimento2, M El-Hakim3, J E Henderson4, R F de Albuquerque Junior5.   

Abstract

The microbial aetiology of bisphosphonate-related osteonecrosis of the jaw (BRONJ) remains undefined. This study investigated the oral microbiota and socket healing after zoledronic acid (ZA) and dexamethasone (DX) administration. Fourteen rats assigned randomly to experimental (n=8) and control (n=6) groups were injected with ZA+DX or saline, respectively, for 3 weeks prior to and 9 weeks after the extraction of left first upper and lower molars. Whole genomic DNA probes of 38 bacterial species and five Candida species were hybridized to DNA extracted from biofilm samples on exposed bone and adjacent teeth. Only experimental rats exhibited exposed bone at euthanasia. All BRONJ-like lesions were colonized by Staphylococcus pasteuri, Streptococcus parasanguinis, and Streptococcus mitis. A significant correlation was observed between the mean proportions of species colonizing BRONJ-like lesions and the teeth of experimental rats (r=0.818, P<0.001). Significant differences were seen in several species colonizing the teeth of control rats compared to experimental rats (P<0.05). Micro-computed tomography analyses revealed higher residual bone in mandibular (P=0.001) and maxillary (P=0.108) tooth sockets of experimental rats. BRONJ-like lesions were colonized mainly by non-pathogenic bacteria. ZA+DX administered to rats at doses equivalent to those given to cancer patients resulted in changes to the oral biofilm and impaired bone healing following tooth extraction.
Copyright © 2015 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DNA checkerboard; bisphosphonates; bone repair; oral biofilm; tooth extraction

Mesh:

Substances:

Year:  2016        PMID: 26780925     DOI: 10.1016/j.ijom.2015.12.017

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  5 in total

1.  The effect of melatonin on prevention of bisphosphonate-related osteonecrosis of the jaw: an animal study in rats.

Authors:  Afshin Yadegari; Atousa Aminzadeh; Sam Seyyedkhamesi; Maedeh Aminian
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2020-08-31

Review 2.  Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  J I Aguirre; E J Castillo; D B Kimmel
Journal:  Bone       Date:  2021-09-11       Impact factor: 4.398

3.  Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients' Gingiva.

Authors:  Mengyu Li; Jiajia Wang; Yejia Yu; Yuqiong Zhou; Yueqi Shi; Wenjie Zhang; Geehun Son; Jing Ge; Jun Zhao; Chi Yang; Shaoyi Wang
Journal:  Stem Cell Rev Rep       Date:  2021-09-22       Impact factor: 5.739

4.  In vivo and in vitro analysis in a rat model using zoledronate and alendronate medication: microbiological and scanning electron microscopy findings on peri-implant rat tissue.

Authors:  Ali Al-Ahmad; Ali Modabber; Kristian Kniha; Eva Miriam Buhl; Stephan Christian Möhlhenrich; Anna Bock; Frank Hölzle; Elmar Hellwig
Journal:  BMC Oral Health       Date:  2021-12-31       Impact factor: 2.757

Review 5.  Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  Ran Yan; Ruixue Jiang; Longwei Hu; Yuwei Deng; Jin Wen; Xinquan Jiang
Journal:  Int J Oral Sci       Date:  2022-08-10       Impact factor: 24.897

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.